SAB Biotherapeutics Statistics

Total Valuation

SABS has a market cap or net worth of $290.56 million. The enterprise value is $189.35 million.

Market Cap	290.56M
Enterprise Value	189.35M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

SABS has 76.46 million shares outstanding. The number of shares has increased by 227.56% in one year.

Current Share Class	76.46M
Shares Outstanding	76.46M
Shares Change (YoY)	+227.56%
Shares Change (QoQ)	+11.59%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	46.11%
Float	41.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.27
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.45, with a Debt / Equity ratio of 0.03.

Current Ratio	11.45
Quick Ratio	11.06
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-248.79

Financial Efficiency

Return on equity (ROE) is -0.32% and return on invested capital (ROIC) is -27.80%.

Return on Equity (ROE)	-0.32%
Return on Assets (ROA)	-25.38%
Return on Invested Capital (ROIC)	-27.80%
Return on Capital Employed (ROCE)	-24.38%
Weighted Average Cost of Capital (WACC)	7.19%
Revenue Per Employee	n/a
Profits Per Employee	-$109,428
Employee Count	86
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +108.79% in the last 52 weeks. The beta is 0.55, so SABS's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+108.79%
50-Day Moving Average	3.69
200-Day Moving Average	3.55
Relative Strength Index (RSI)	53.35
Average Volume (20 Days)	1,140,503

Short Selling Information

The latest short interest is 2.64 million, so 3.46% of the outstanding shares have been sold short.

Short Interest	2.64M
Short Previous Month	2.75M
Short % of Shares Out	3.46%
Short % of Float	6.42%
Short Ratio (days to cover)	2.63

Income Statement

Revenue	n/a
Gross Profit	-39.09M
Operating Income	-58.18M
Pretax Income	-398,429
Net Income	-9.41M
EBITDA	-55.12M
EBIT	-58.18M
Earnings Per Share (EPS)	-$2.05

Full Income Statement

Balance Sheet

The company has $107.39 million in cash and $6.17 million in debt, giving a net cash position of $101.22 million or $1.32 per share.

Cash & Cash Equivalents	107.39M
Total Debt	6.17M
Net Cash	101.22M
Net Cash Per Share	$1.32
Equity (Book Value)	227.25M
Book Value Per Share	3.00
Working Capital	102.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.25 million and capital expenditures -$1.92 million, giving a free cash flow of -$53.17 million.

Operating Cash Flow	-51.25M
Capital Expenditures	-1.92M
Depreciation & Amortization	3.06M
Net Borrowing	-283,887
Free Cash Flow	-53.17M
FCF Per Share	-$0.70

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-227.56%
Shareholder Yield	-227.56%
Earnings Yield	-3.24%
FCF Yield	-18.30%

Analyst Forecast

The average price target for SABS is $11.18, which is 194.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.18
Price Target Difference	194.21%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 5, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 5, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1